Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2023
Soletti, Jr G, Perezgrovas-Olaria R, Dimagli A, Harik L, Rong LQ, C Merz NBairey, Rahouma M, Sandner SE, Gelijns AC, Gaudino M.  2023.  Gender Disparities in Cardiac Surgery Trials: Leadership, Authorship, and Patient Enrollment.. Ann Thorac Surg.
Platholi J, Marongiu R, Park L, Yu F, Sommer G, Weinberger R, Tower W, Milner TA, Glass MJ.  2023.  Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy.. Front Aging Neurosci. 15:1280218.
Platholi J, Marongiu R, Park L, Yu F, Sommer G, Weinberger R, Tower W, Milner TA, Glass MJ.  2023.  Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy.. Front Aging Neurosci. 15:1280218.
Mehta N, Slatkin NE, Israel RJ, Stambler N, Shah ED.  2023.  Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.. J Pain Res. 16:3529-3543.
Makkad B, Heinke TLee, Sheriffdeen R, Khatib D, Brodt JLouise, Meng M-L, Grant MConrad, Kachulis B, Popescu WMaria, Wu CL et al..  2023.  In Response.. Anesth Analg. 137(6):e52-e53.
Makkad B, Heinke TLee, Sheriffdeen R, Khatib D, Brodt JLouise, Meng M-L, Grant MConrad, Kachulis B, Popescu WMaria, Wu CL et al..  2023.  In Response.. Anesth Analg. 137(6):e52-e53.
Gari RRSanganna, Tagiltsev G, Pumroy RA, Jiang Y, Blackledge M, Moiseenkova-Bell VY, Scheuring S.  2023.  Intrinsically disordered regions in TRPV2 mediate protein-protein interactions.. Commun Biol. 6(1):966.
Pilato TC, Taki F, Sbrollini K, Drake APurington, Maley B, Yale-Loehr S, Powers JL, Bazarova NN, Bhandari A, Kaur G.  2023.  Knowledge of legal rights as a factor of refugee and asylum seekers' health status: a qualitative study.. BMJ Open. 13(2):e063291.
Rubin JE, Pandian B, Jotwani R, Pryor KO, Rubin LA, Mack PF.  2023.  Leveraging spatial computing to improve crisis management training in anesthesiology.. J Clin Anesth. 93:111358.
Petersen EA, Stauss TG, Scowcroft JA, Jaasma MJ, Brooks ES, Edgar DR, White JL, Sills SM, Amirdelfan K, Guirguis MN et al..  2023.  Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial.. Diabetes Res Clin Pract. 203:110865.
Petersen EA, Stauss TG, Scowcroft JA, Jaasma MJ, Brooks ES, Edgar DR, White JL, Sills SM, Amirdelfan K, Guirguis MN et al..  2023.  Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial.. Diabetes Res Clin Pract. 203:110865.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Rauck RL, Loudermilk E, Thomson SJ, Paz-Solis JFrancisco, Bojrab L, Noles J, Vesper J, Atallah J, Roth D, Hegarty J et al..  2023.  Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain.. Pain Manag. 13(2):115-127.
Durbhakula S, Toy S, Acosta CA, Barman RA, Kelner AF, Issa MA, Broachwala MY, Marascalchi BJ, Navalgund YA, Pak DJ et al..  2023.  Needs-based novel digital curriculum for the neuromodulation training deficit: Pain Rounds.. Reg Anesth Pain Med.
Durbhakula S, Toy S, Acosta CA, Barman RA, Kelner AF, Issa MA, Broachwala MY, Marascalchi BJ, Navalgund YA, Pak DJ et al..  2023.  Needs-based novel digital curriculum for the neuromodulation training deficit: Pain Rounds.. Reg Anesth Pain Med.
Durbhakula S, Toy S, Acosta CA, Barman RA, Kelner AF, Issa MA, Broachwala MY, Marascalchi BJ, Navalgund YA, Pak DJ et al..  2023.  Needs-based novel digital curriculum for the neuromodulation training deficit: Pain Rounds.. Reg Anesth Pain Med.
Scarpa JR, Montagna G, Plitas G, Gulati A, Fischer GW, Mincer JS.  2023.  Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer.. Front Oncol. 13:1267532.
Scarpa JR, Montagna G, Plitas G, Gulati A, Fischer GW, Mincer JS.  2023.  Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer.. Front Oncol. 13:1267532.